Gold Nanocrystals

DRUG3 trials

Sponsors

Clene Nanomedicine

Conditions

Amyotrophic Lateral SclerosisMultiple SclerosisParkinson's Disease

Phase 2

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease

CompletedNCT03815916

Clene NanomedicineParkinson's Disease

Start: 2019-12-19End: 2021-06-07Updated: 2024-05-16

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)

WithdrawnNCT03843710

Clene NanomedicineAmyotrophic Lateral Sclerosis

Start: 2020-03-31End: 2022-03-31Updated: 2023-04-03

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.

CompletedNCT03993171

Clene NanomedicineMultiple Sclerosis

Start: 2019-12-19End: 2025-07-31Updated: 2025-12-19